Zum Hauptinhalt springen

Naltrexon

22. April 2021 | Naltrexon

Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial

Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial Collins, Susan E et al. The Lancet Psychiatry, Volume 8, Issue 4,...

14. März 2021 | Naltrexon

Enablers and hindrances for longer-term abstinence in opioid dependent individuals receiving treatment with extended-release naltrexone: A Norwegian longitudinal recovery trial (NaltRec study).

Enablers and hindrances for longer-term abstinence in opioid dependent individuals receiving treatment with extended-release naltrexone: A Norwegian longitudinal recovery trial (NaltRec study). Weimand BM, Solli KK, Reichelt WH, Tanum L.&nb...

21. Februar 2021 | Naltrexon

A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder.

A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder. Sibai M, Mishlen K, Nunes EV, Levin FR, Mariani JJ, Bisaga A. Am J Drug Alcohol Abuse. 2020 May 3;46(3):289-296. doi: 10.1080/00952990.2019.170...

03. Februar 2021 | Naltrexon

Adapting treatment length to opioid‐dependent individuals’ needs and preferences: a 2‐year follow‐up to a 1‐year study of extended‐release naltrexone.

Adapting treatment length to opioid‐dependent individuals’ needs and preferences: a 2‐year follow‐up to a 1‐year study of extended‐release naltrexone. Solli, K. K., Opheim, A., Latif, Z., Krajci, P., Benth, Jė. Š., Kunoe, N., and Tanum, L. ...

25. Dezember 2020 | Naltrexon

Naltrexone-Associated Non-ST-Elevated Myocardial Infarction.

Naltrexone-Associated Non-ST-Elevated Myocardial Infarction. Gubitosa JC, Terwillliger T, Ukazu A, Gordon E. Cureus. 2020 Oct 27;12(10):e11198. doi: 10.7759/cureus.11198. PMID: 33269129; PMCID: PMC7703987. https://www.ncbi.nlm.nih.g...

09. Oktober 2020 | Naltrexon

Biased Opioid Antagonists as Modulators of Opioid Dependence: Opportunities to Improve Pain Therapy and Opioid Use Management.

Biased Opioid Antagonists as Modulators of Opioid Dependence: Opportunities to Improve Pain Therapy and Opioid Use Management. Sadee W, Oberdick J, Wang Z. Molecules. 2020 Sep 11;25(18):E4163. doi: 10.3390/molecules25184163. PMID: 32...

09. Oktober 2020 | Naltrexon

Naloxone-Induced Acute Opioid Withdrawal in a Stabilized Extended-Release Naltrexone-Treated Patient.

Naloxone-Induced Acute Opioid Withdrawal in a Stabilized Extended-Release Naltrexone-Treated Patient. Spitzberg AJ, Urner EM, Wirshing WC. Prim Care Companion CNS Disord. 2020 Sep 17;22(5):20l02590. doi: 10.4088/PCC.20l02590. PMID: 3...

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten